COLORECTAL CANCER (MSI-H)
Clinical trials for COLORECTAL CANCER (MSI-H) explained in plain language.
Never miss a new study
Get alerted when new COLORECTAL CANCER (MSI-H) trials appear
Sign up with your email to follow new studies for COLORECTAL CANCER (MSI-H), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy aims to shrink Hard-to-Treat colorectal tumors before surgery
Disease control Not yet recruitingThis study tests whether giving immunotherapy drugs (nivolumab with or without ipilimumab) or immunotherapy plus radiotherapy before surgery can improve outcomes for people with a specific genetic type of colorectal cancer called MSI-H/dMMR. About 114 participants will be randoml…
Matched conditions: COLORECTAL CANCER (MSI-H)
Phase: PHASE2 • Sponsor: Fudan University • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
New device could make colon polyp removal safer and faster
Symptom relief Not yet recruitingThis study tests a new traction device called SureTrac to help doctors remove large colorectal lesions (precancerous growths) more easily. The device pulls the lesion upward during a procedure called submucosal dissection, which may make the surgery faster, safer, and more likely…
Matched conditions: COLORECTAL CANCER (MSI-H)
Phase: NA • Sponsor: GCS Ramsay Santé pour l'Enseignement et la Recherche • Aim: Symptom relief
Last updated Jun 27, 2026 08:00 UTC